SEATTLE — Lightspeed Microscopy, Inc., developers of an innovative end-to-end 3D spatial biology platform, has announced today that the company will begin operating under the name Alpenglow Biosciences, effective immediately. The company’s ownership and staff remain unchanged. CEO, Nicholas Reder, MD, MPH stated “Our rebranding as Alpenglow Biosciences represents the evolution of our company towards […]
Data interpretation is by far the most time-consuming and resource-intensive step of the NGS workflow. Any time savings that can be found have a significant impact on overall costs and sample throughput. The release of Congenica v3.3, the first of our product releases for 2022, enables our customers to benefit from the use of Congenica’s […]
Alliance pairs ultra-high-speed cell imaging technology with industry-leading lab automation solution SAN DIEGO — Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, today announced a collaboration with Araceli Biosciences that will allow scientists to integrate Araceli’s Endeavor™ high-speed imaging platform into automated workflows controlled by Biosero’s Green Button Go® software suite. The Endeavor platform offers […]
Informatics Capabilities Help Expand BD Data Analytics Capabilities and Understanding of Cancer and Other Chronic Diseases FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of Cytognos, a privately held company headquartered in Salamanca, Spain, specializing in flow cytometry solutions […]
LONGMONT, Colo. — Building on over ten years of experience in the cell culture and isolation of cell products, KromaTiD is excited to announce the launch of a comprehensive suite of Cell and Blood Culture growth, isolation, processing, and quality control services. Focused on the cell types most important for gene and cell therapy and oncology […]
SOUTH SAN FRANCISCO, Calif.–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today released its inaugural environmental social and governance (ESG) report highlighting Twist’s approach to sustainability, social responsibility and commitment to ethics. The full report is available to view at https://www.twistbioscience.com/company/esg. […]
VIENNA — Ribbon Biolabs, the DNA synthesis company, today announced the successful close of EUR 18 million in its Series A funding round from a consortium of European and US investors led by Hadean Ventures and with participation from Lansdowne Partners, Helicase Venture as well as several undisclosed investors. Existing investors IST cube and tecnet equity […]
HERCULES, Calif. – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today introduced four inhibitory antibodies that are highly specific to pertuzumab (Perjeta). These ready-made antibodies inhibit the binding of the drug to its target, human epidermal growth factor 2 (HER2), enabling researchers to develop […]
Brings Significant Operational Experience in Building Therapeutic Drug Development Businesses TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced it has appointed biopharmaceutical industry veteran Christopher Kiritsy to its Board of Directors. Currently the Managing Member of Precision Kapital, LLC, a private […]
MyChem’s nucleotide synthesis methods are highly complementary to Maravai’s TriLink mRNA technologies Increases capabilities serving the high-growth cell and gene therapy market SAN DIEGO — Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today that it has acquired MyChem, LLC for $240 million in […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
